on person weight loss Travel should not be solely dependent on anti-obesity drugs, according to a statement from the National Nutrition Association.
The Academy of Nutrition and Dietetics released a statement on March 4, World Obesity Day.
“The Academy is appealing to the medical community, including pharmaceutical manufacturers of anti-obesity drugs, obesity drug providers, and others. Health care workers “The University of Chicago is proud to be a leader in the University of Chicago,” said Dr. Lori Wright, president of the University of Chicago. -Based Academy.
Obesity is ‘exploding’, study finds more than 12% of people worldwide are classified as obese: ‘huge problem’
” anti-obesity drugs “On its own, obesity cannot be eliminated unless combined with an interprofessional, collaborative approach that includes policy changes to reduce health inequalities and disparities,” she said in a release.
In a statement to Fox News Digital, Wright emphasized the need to overcome obstacles to obesity treatment.
The National Nutrition Association said Monday, March 4, that people on weight loss journeys should not rely solely on anti-obesity drugs. (St. Petersburg)
“We need to reevaluate how we treat and prevent obesity by increasing access to nutritious foods and increasing health insurance plans that cover nutritional services,” she says.
“Medical nutrition therapy and intensive behavioral therapy with a registered dietitian are both proven and cost-effective.”
The Academy of Nutrition and Dietetics released a statement on March 4, World Obesity Day. “We need to reevaluate how we treat and prevent obesity, including increasing access to nutritious foods and health insurance plans that cover nutritional services,” the group’s president said. (St. Petersburg)
Semaglutide is a type of drug known as a GLP-1 receptor agonist, which includes Ozempic (such as Ozempic). diabetes management), Wegovy (prescribed for weight loss), Rybelsus (type 2 diabetes), and Saxenda (weight loss) have skyrocketed in popularity in recent years.
Studies show that the number of people using GLP-1 agonists to treat diabetes or obesity in the United States will reach 40 million by 2022.
Ozempic and Wigoby overdose calls are on the rise, experts say – here’s what you need to know about dangerous doses
Professor Wright said in a statement to the society that obesity is a “complex, chronic and progressive disease with significant morbidity and mortality risks”.
“Establishing World Obesity Day during National Nutrition Month is an important step towards anti-obesity to ensure that all patients have access to both lifestyle interventions and safe and effective medicines that can reverse obesity. This is an opportunity to re-evaluate how best to use drugs. health of many adults In the United States,” she added.
Semaglutide is a class of drugs known as GLP-1 receptor agonists, which include Ozempic (prescribed for diabetes management), Wigovy (prescribed for weight loss), Libersus (type 2 diabetes), and Saxenda (weight loss), which have recently become popular. is rapidly increasing. Year. (Getty Images)
The academy said it plans to release a white paper in the spring with detailed recommendations for lifestyle interventions.
Doctors express their opinions on the academic society’s position
Dr. Mark Siegel, Clinical Professor, School of Medicine New York University Langone Medical Center and a Fox News medical contributor responded to this statement in a conversation with Fox News Digital.
“On World Obesity Day, it is important to shine a spotlight on this large and rapidly growing problem,” he said.
Ozempic, the happy drug? Study suggests weight loss drug may reduce depression and anxiety
“There are over 1 billion obese people in the world, Obesity rate 40% We have a big problem in the US. ”
Professor Siegel agreed with the academy’s position, but pointed out that not all obese patients need to take weight loss drugs.
Managing obesity requires a multifaceted approach that combines proper nutrition and exercise, and also takes into account psychosocial factors, one doctor told Fox News Digital. (St. Petersburg)
“The Academy of Nutrition and Dietetics is right to spotlight this, but this changing focus will likely require the prescription of anti-obesity drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). It is wrong to suggest that.”
Given the “tremendous shortage” of these drugs, Siegel warned that many diabetics who need them cannot get them.
“At the same time, not everyone can tolerate them well, and we still don’t fully understand the long-term side effects,” the doctor said.
Vibratory weight loss drug could replace Ozempic and Wigovy, researchers say
“I certainly think they are useful, and I can think of many situations where they not only reduce the risk of heart disease, stroke, diabetes, and cancer, but also reduce the need for medical care. I can. bariatric surgery — but they are certainly not panacea and most are not first-line treatments. ”
To promote healthy weight management, Siegel recommended gaining weight. daily exercise Adopt a diet rich in vegetables and fiber and low in “empty calories.”
“With more than 1 billion obese people in the world and an obesity rate of over 40% in the United States, we have a huge problem.”
Dr. Brett Osborn, a Florida neurologist and longevity expert, is a big advocate of the drug semaglutide as a “very powerful” treatment in the fight against obesity.
“They really are the holy grail of modern medicine and will probably have a similar impact on global health as the advent of antibiotics in the early 1900s,” he predicted on Fox News Digital.
CLICK HERE TO GET THE FOX NEWS APP
Mr Osborne said he agreed with the academy’s recommendations.
“Managing obesity is complex,” he told Fox News Digital. “This is best done through a multi-pronged approach that focuses on: proper nutrition, exercise and psychosocial factors. Without all three, we cannot expect long-term and sustainable results. ”
One doctor said a diet should be rich in vegetables and fiber and low in “empty calories” to promote healthy weight management. (St. Petersburg)
Drugs like Ozempic and Munjaro have “changed the landscape of obesity management,” Osborne said.
“These drugs send strong satiety signals to the brain, forcing it to say ‘just say no,’ resulting in a calorie deficit and weight loss,” he said.
Click here to sign up for our health newsletter
“But without exercise and proper design, Diet based on macronutrients Because they are rich in protein, fat, and carbohydrates, they can leave you relatively malnourished and weaken your immune system. ”
For this reason, Osborne recommended that drugs such as Ozempic and Munjaro should always be prescribed along with nutrition and exercise counseling.
Fox News Digital has reached out to Novo Nordisk, the maker of Ozempic and Wegovy, for comment.
For more health articles, visit: www.foxnews.com/health.
